文献速递肝病

持续家庭特利加压素输注提高握力并减少腹水——一项前瞻性随机交叉研究

Continuous home terlipressin infusion increases handgrip strength and reduces ascites-A prospective randomized crossover study.
PubMed 文献 · Hepatology · 2024-03-05

这项单中心前瞻性随机交叉研究将30例肝硬化腹水合并肌少症患者随机分配至先接受12周家庭持续特利加压素输注(CTI)或先观察12周后交叉。结果显示CTI较观察显著提高握力(平均校正差值3.09 kg,95%CI 1.11-5.08 kg,P=0.006),减少腹水引流总量(平均校正差值11.39 L,2.99-19.85,P=0.01)及穿刺次数,并改善生活质量。

要点

  • CTI较观察提高握力平均校正差值3.09 kg(95%CI 1.11-5.08 kg,P=0.006),较基线增加11.8%。
  • CTI较观察减少腹水引流总量平均校正差值11.39 L(2.99-19.85,P=0.01),穿刺次数减少1.75次(0.925-2.59,P<0.001)。
  • CTI期间血肌酐下降、尿钠排泄增加、生活质量显著提高(均P<0.001),7例轻微管路相关并发症,无心脏事件或肺水肿。

核心结论

  • 本新研究显示,接受持续特利加压素输注的失代偿期肝硬化患者握力显著增加、穿刺引流量减少且生活质量改善。
  • 这些发现为在适当选择的肝硬化患者中使用门诊CTI提供了强有力的依据。

研究设计与样本

  • 单中心、前瞻性、交叉研究,30例肝硬化腹水合并肌少症患者随机分配至先接受12周家庭CTI或先观察12周后交叉。
  • 共同主要结局为握力和穿刺引流量变化。
  • 参与者中位年龄62岁(IQR:57-64),中位MELD-Na评分16(12.3-20.8),男性22例(73%)。

主要发现

  • CTI与观察之间握力平均校正差值为3.09 kg(95%CI:1.11-5.08 kg,P=0.006),较基线增加11.8%。
  • CTI期间腹水引流总量平均校正差值减少11.39 L(2.99-19.85,P=0.01),穿刺次数减少1.75次(0.925-2.59,P<0.001)。
  • CTI期间血肌酐下降、尿钠排泄增加、生活质量显著更高(均P<0.001),慢性肝病问卷评分增加0.41分(0.23-0.59)。
  • 出现7例轻微管路相关并发症,无心脏事件或肺水肿。

临床怎么用

  • 作者认为这些发现为在适当选择的肝硬化患者中使用门诊CTI提供了强有力的依据。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Observational studies suggest a beneficial effect of continuous terlipressin infusion (CTI) on ascites and sarcopenia in decompensated cirrhosis with portal hypertension. APPROACH AND RESULTS: This single-center, prospective, cross-over study randomized 30 patients with cirrhosis, ascites, and sarcopenia to commence on 12 weeks of home CTI or 12 weeks of observation prior to cross-over. The co-primary outcomes were change in handgrip strength and paracentesis volume. Secondary outcomes included quality of life, sarcopenia measures, renal function, safety, and hospitalization. The median age of participants was 62 years (IQR: 57-64), the median Model for End-Stage Liver Disease-Sodium was 16 (12.3-20.8), and 22 (73%) were male. Handgrip strength increased by a mean adjusted difference (MAD) of 3.09 kg (95% CI: 1.11-5.08 kg) between CTI and observation ( p =0.006); an 11.8% increase from baseline. The total volume of ascites drained decreased by a MAD of 11.39L (2.99-19.85, p =0.01), with 1.75 fewer episodes of paracentesis (0.925-2.59, p <0.001) on CTI. Serum creatinine decreased, urinary sodium excretion increased, and quality of life was significantly higher on CTI (all p <0.001), with an increase in Chronic Liver Disease Questionnaire score of 0.41 points (0.23-0.59). There were 7 minor line-related complications but no cardiac events or pulmonary edema. CONCLUSIONS: This novel study demonstrates a significant increase in handgrip strength, reduction in paracentesis volume, and improved quality of life in patients with decompensated cirrhosis treated with continuous terlipressin infusion. These findings provide a strong rationale for the use of ambulatory CTI in appropriately selected patients with cirrhosis.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Terbah R, Testro AG, Hoermann R, et al. Continuous home terlipressin infusion increases handgrip strength and reduces ascites-A prospective randomized crossover study. Hepatology. 2024. PMID: 38442012. doi:10.1097/HEP.0000000000000820

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。